Only tumors with lower enzymes showed improved outcome with temozolomide. »
09/24/15

ADAM15 catalytic domain may represent a viable therapeutic target in patients with advanced disease. »
03/04/16

Epidemiological evidence that beta-blockers improve BC-specific survival. »
11/25/15

Faecal MMP-9 identified high-risk adenomas besides CRC. »
03/23/15

Combinatorial use of the mTOR inhibitor and AKT inhibitor MK2206 robustly inhibited the growth and viability of squamous lung tumors. »
11/18/15

Inhibition of uc.206 effectively delays cervical cells proliferation. »
03/02/16

FACT expression was elevated in GBM tumors compared to non-neoplastic brain tissues. »
02/13/16

Plasma levels of miR-92a, miR-100 and miR-143 were significantly lower in BC patients. »
10/17/15

Negative association between BMI in late childhood and the adult mammographic density measures that predict breast cancer risk. »
12/10/15

Detection of TMPRSS2-ERG in blood from metastatic resistant prostate cancer patients predicts resistance to docetaxel. »
12/16/15